{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:15:44Z","timestamp":1787318144795,"version":"build-2736575974"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the anti-seizure efficacy and safety of a C10-enriched medium-chain triglyceride (MCT) ketogenic diet (KD) compared with the classic KD in pediatric patients with refractory epilepsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This 16-week, open-label, randomized, controlled, crossover pilot study was conducted at Severance Children\u2019s Hospital, Seoul, South Korea, between August 2022 and September 2023. Fifteen pediatric patients with refractory epilepsy were enrolled and received classic KD and C10-enriched KD for 8\u202fweeks each. The study compared seizure reduction rate, tolerability, and safety of the two diets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen patients were enrolled. Patients were divided into 2 groups depending on the type of KD initiated. Ten patients completed the trial. Initial treatment with the C10-enriched KD resulted in seizure reduction in all five patients, with two becoming seizure-free. Initial treatment with classic KD was effective in two out of five patients. Upon crossover, those initially on C10-enriched KD maintained their seizure reduction, while patients initially on the classic KD showed additional seizure reduction when switched to C10-enriched KD. Adverse effects included transient hypoglycemia, metabolic acidosis, hypercalciuria, and gastrointestinal symptoms, all of which were manageable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The C10-enriched KD demonstrated comparable efficacy and tolerability to the classic KD, offering a promising option for patients with refractory epilepsy who do not respond adequately to the classic KD alone. This study, the first to directly compare a C10-enriched KD with a classic KD, highlights the potential synergistic effects of decanoic acid.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1524799","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T10:08:22Z","timestamp":1737972502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Decanoic acid-enriched ketogenic diet in refractory epilepsy"],"prefix":"10.3389","volume":"16","author":[{"given":"Hui Jin","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonae","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NaRae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon-Chul","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung Dong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/jnc.12646","article-title":"The ketogenic diet component Decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells","volume":"129","author":"Hughes","year":"2014","journal-title":"J Neurochem"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/nu12082379","article-title":"Mechanism of action of ketogenic diet treatment: impact of Decanoic acid and Beta-Hydroxybutyrate on Sirtuins and energy metabolism in hippocampal murine neurons","volume":"12","author":"Dabke","year":"2020","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"23617","DOI":"10.1073\/pnas.2008980117","article-title":"Decanoic acid inhibits Mtorc1 activity independent of glucose and insulin signaling","volume":"117","author":"Warren","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1111\/epi.14578","article-title":"Perampanel and Decanoic acid show synergistic action against Ampa receptors and seizures","volume":"59","author":"Augustin","year":"2018","journal-title":"Epilepsia"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pnpbp.2014.10.013","article-title":"Acute anticonvulsant effects of Capric acid in seizure tests in mice","volume":"57","author":"Wla\u017a","year":"2015","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1528-1167.2008.01870.x","article-title":"A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy","volume":"50","author":"Neal","year":"2009","journal-title":"Epilepsia"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1017\/cjn.2021.122","article-title":"Ketonuria and seizure control in the medium chain triglyceride and classic ketogenic diets","volume":"49","author":"Lowe","year":"2022","journal-title":"Can J Neurol Sci"},{"key":"ref8","first-page":"159","article-title":"Effectiveness of medium chain triglyceride ketogenic diet in Thai children with intractable epilepsy","volume":"99","author":"Chomtho","year":"2016","journal-title":"J Med Assoc Thail"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s42494-024-00150-x","article-title":"Efficacy and safety of modified medium-chain triglyceride ketogenic diet in patients with drug-resistant epilepsy","volume":"6","author":"Li","year":"2024","journal-title":"Acta Epileptol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.26815\/acn.2022.00094","article-title":"A mixed-lipid diet (medium-chain and long-chain triglycerides) for better tolerability and efficiency in pediatric epilepsy patients. Annals of child","volume":"30","author":"Rita Yu","year":"2022","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/epi4.12910","article-title":"Tolerance, adherence, and acceptability of a ketogenic 2.5:1 ratio, nutritionally complete, medium chain triglyceride-containing liquid feed in children and adults with drug-resistant epilepsy following a ketogenic diet","volume":"9","author":"Griffen","year":"2024","journal-title":"Epilepsia Open"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"fcab160","DOI":"10.1093\/braincomms\/fcab160","article-title":"Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy","volume":"3","author":"Schoeler","year":"2021","journal-title":"Brain Commun"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1016\/j.eclnm.2010.08.001","article-title":"Usefulness of liquid ketogenic Milk for intractable childhood epilepsy","volume":"5","author":"Lee","year":"2010","journal-title":"e-SPEN, Eur J Clin Nutr Metab"},{"key":"ref14","volume-title":"The epilepsy diet treatment: An introduction to the ketogenic diet","author":"Freeman","year":"1996"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.0013-9580.2005.48504.x","article-title":"Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience","volume":"46","author":"Chul Kang","year":"2005","journal-title":"Epilepsia"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.clnu.2012.05.019","article-title":"Catch-up growth after long-term implementation and weaning from ketogenic diet in pediatric epileptic patients","volume":"32","author":"Kim","year":"2013","journal-title":"Clin Nutr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3988\/jcn.2015.11.1.26","article-title":"Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis","volume":"11","author":"Ye","year":"2015","journal-title":"J Clin Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/clinchem\/28.4.642","article-title":"Monitoring Octanoic and Decanoic acids in plasma from children with intractable epilepsy treated with medium-chain triglyceride diet","volume":"28","author":"Haidukewych","year":"1982","journal-title":"Clin Chem"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/adc.61.12.1173","article-title":"Role of Octanoic and Decanoic acids in the control of seizures","volume":"61","author":"Sills","year":"1986","journal-title":"Arch Dis Child"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/s1474-4422(23)00370-8","article-title":"Classic ketogenic diet versus further Antiseizure medicine in infants with drug-resistant epilepsy (Kiwe): a Uk, multicentre, open-label","volume":"22","author":"Schoeler","year":"2023","journal-title":"Randomised Clin Trial Lancet Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/epi.13833","article-title":"Neuronal Decanoic acid oxidation is markedly lower than that of Octanoic acid: a mechanistic insight into the medium-chain triglyceride ketogenic diet","volume":"58","author":"Khabbush","year":"2017","journal-title":"Epilepsia"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/brain\/awv325","article-title":"Seizure control by Decanoic acid through direct Ampa receptor inhibition","volume":"139","author":"Chang","year":"2016","journal-title":"Brain"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5607\/en.2018.27.5.365","article-title":"Fatty acid increases camp-dependent lactate and Mao-B-dependent Gaba production in mouse astrocytes by activating a G (\u0391s) protein-coupled receptor","volume":"27","author":"Lee","year":"2018","journal-title":"Exp Neurobiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13041-021-00842-2","article-title":"Astrocyte metabolism of the medium-chain fatty acids Octanoic acid and Decanoic acid promotes Gaba synthesis in neurons via elevated glutamine supply","volume":"14","author":"Andersen","year":"2021","journal-title":"Mol Brain"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuropharm.2012.11.004","article-title":"Seizure control by ketogenic diet-associated medium chain fatty acids","volume":"69","author":"Chang","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1177\/0271678x16659498","article-title":"Tridecanoin is anticonvulsant, antioxidant, and improves mitochondrial function","volume":"37","author":"Tan","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/epi.13809","article-title":"Synergistic protection against acute Flurothyl-induced seizures by adjuvant treatment of the ketogenic diet with the type 2 diabetes drug pioglitazone","volume":"58","author":"Simeone","year":"2017","journal-title":"Epilepsia"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40538-020-00194-4","article-title":"Effects of ketogenic diet containing medium-chain fatty acids on serum inflammatory factor and Mtor signaling pathway in rats","volume":"7","author":"Liu","year":"2020","journal-title":"Chem Biol Technol Agric"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/bf00735398","article-title":"Production and disposal of medium-chain fatty acids in children with medium-chain acyl-Coa dehydrogenase deficiency","volume":"17","author":"Heales","year":"1994","journal-title":"J Inherit Metab Dis"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1524799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T10:08:24Z","timestamp":1737972504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1524799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":29,"alternative-id":["10.3389\/fneur.2025.1524799"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1524799","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"article-number":"1524799"}}